StocksMedium•12 November 2026•
1 min read
MediPharm Labs Reports Second Consecutive Quarter of Positive Net Income in Q3 2026
Key Facts
1MediPharm Labs reported positive net income for the second consecutive quarter and revenue of $11.8M.
2Revenue grew 18% sequentially, driven by a 19% increase in German revenue.
3Operating expenses decreased 25% year-over-year, with the company remaining virtually debt-free.
MediPharm Labs reported positive net income for the second consecutive quarter and revenue of $11.8 million for the third quarter of 2026. GlobeNewswire reported that revenue grew 18% sequentially, driven primarily by a 19% increase in sales from the German market.
Operating expenses decreased by 25% year-over-year, with the company remaining virtually debt-free according to its financial results. MediPharm Labs noted that over 55% of its revenue for the first nine months of 2026 was generated through international channels, while cash reserves increased to $10.1 million as of September 30, 2026.